News

Check all IrsiCaixa scientific news in just one click.

Post COVID-19

Epigenetics

19/09/2022

An IrsiCaixa project to study Long Covid, one of the 9 Catalan proposals selected by the CaixaResearch call for Health Research 2022

SARS-CoV-2

Vaccines

Antibodies

21/07/2022

HIPRA’s COVID-19 vaccine induces a good neutralising antibody response against the new subvariants of Omicron

SARS-CoV-2

Vaccines

14/07/2022

COVID-19 vaccines: is a second booster necessary at this moment, and for whom?

SARS-CoV-2

Therapies

10/07/2022

Study shows that adding a new antiviral to current COVID-19 treatment could reduce mortality in hospitalised patients by 30%

HIV

SARS-CoV-2

07/07/2022

Three IrsiCaixa female researchers receive funding from Gilead to keep progressing in the field of HIV and COVID-19

Alumni

28/06/2022

The IAN Talks are back, the meeting point for IrsiCaixa alumni

Therapies

27/06/2022

Common antiretroviral drug improves cognition in mouse model of Down syndrome

Microbiome

SARS-CoV-2

HIV

26/06/2022

Predicting the progression of SARS-CoV-2 and HIV infection by studying the microbiome

SARS-CoV-2

Prevention

22/06/2022

CPC in mouthwashes is shown in humans to break the membrane of SARS-CoV-2 and reduce the amount of active virus in saliva